Tempus
  • PROVIDERS
  • LIFE SCIENCES
  • PATIENTS
  • OUR PLATFORM
ORDER A TEST Log In Contact Us
Tempus
ORDER A TEST Log In Contact Us
  • Providers
  • Oncology
  • Neurology & Psychiatry
  • Infectious Disease
  • Cardiology
  • Academic & Research
  • EMR Integration
  • Life Sciences
  • Sequencing
  • Companion Diagnostics
  • Clinical Trial Solutions
  • Data Collaborations
  • AI Applications
  • Biological Modeling
  • Patients
  • Oncology Patients
  • Neurology Patients
  • Infectious Disease Patients
  • Our Platform
  • Genomic Profiling
  • Clinical Trial Matching
  • Companion Diagnostics
  • Multi-Omics
  • Tempus ONE
  • Infectious Disease
  • About Us
  • Our Team
  • Careers
  • Culture
  • Resources
  • Publications
  • News
  • Blog
Back to Our Team
Previous Next

Keith Stewart, MB.ChB., MBA

Scientific Advisor

Keith Stewart, MB.ChB., MBA

Dr. Keith Stewart serves as Scientific Advisor at Tempus. He is a consultant in the Division of Hematology and Oncology, at Mayo Clinic. He currently serves as the Carlson and Nelson Endowed Director of the Mayo Clinic Center for Individualized Medicine and is recognized as the Vasek and Anna Maria Polak Professor of Cancer Research. Dr. Stewart’s current responsibilities at Mayo Clinic relate to the application of genomics to human health across the spectrum of discovery, translation and application to clinical practice.

Dr. Stewart has served in several leadership roles across both research and clinical practice at Mayo Clinic, including as Dean for research in Arizona, and as a member of the Arizona Executive Operations Team and Clinical Practice committee. He has served on multiple boards for both non-profit and commercial organizations, including currently as a Non-Executive Board member for Genomics England and the Scientific Advisory Boards of Helix Inc., Veritas Genetics Inc., and the Multiple Myeloma Research Foundation investment fund.

His own research interest is in the genomics and treatment of myeloma and he has led numerous clinical trials of new drugs for this blood cancer. Dr. Stewart and has authored over 300 journal articles, is named on 28 patents and has served as an associate editor of Blood and ASH Clinical News.

ORDER A TEST Log In Contact Us
  • Facebook Opens a new window
  • Twitter Opens a new window
  • Linkedin Opens a new window
  • YouTube Opens a new window
  • Providers
  • Oncology
  • Neurology & Psychiatry
  • Infectious Disease
  • Cardiology
  • Academic & Research
  • EMR Integration
  • Life Sciences
  • Sequencing
  • Companion Diagnostics
  • Clinical Trial Solutions
  • Data Collaborations
  • AI Applications
  • Biological Modeling
  • Patients
  • Oncology Patients
  • Neurology Patients
  • Infectious Disease Patients
  • Our Platform
  • Genomic Profiling
  • Clinical Trial Matching
  • Companion Diagnostics
  • Multi-Omics
  • Tempus ONE
  • Infectious Disease
  • About Us
  • Our Team
  • Careers
  • Culture
  • Resources
  • Publications
  • News
  • Blog
  • Responsible Disclosure
  • FAQ
  • Media Library
  • Document Library
  • Responsible Disclosure
  • FAQ
  • Media Library
  • Document Library
Tempus

All Content Copyright 2022| Privacy Policy| Notice of Privacy Practices| Terms of Use

Understand how your unique genes may respond to medications with the Tempus Genetic Test.

My provider ordered a test
I am a patient and would like to order a test
×